A detailed history of Fort Point Capital Partners LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Fort Point Capital Partners LLC holds 1,172 shares of LLY stock, worth $923,758. This represents 0.13% of its overall portfolio holdings.

Number of Shares
1,172
Previous 989 18.5%
Holding current value
$923,758
Previous $895,000 15.98%
% of portfolio
0.13%
Previous 0.11%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$772.14 - $960.02 $141,301 - $175,683
183 Added 18.5%
1,172 $1.04 Million
Q2 2024

Aug 14, 2024

SELL
$724.87 - $909.04 $1.09 Million - $1.37 Million
-1,504 Reduced 60.33%
989 $895,000
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $5,922 - $7,922
-10 Reduced 0.4%
2,493 $1.94 Million
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $2,625 - $3,095
5 Added 0.2%
2,503 $1.46 Million
Q3 2023

Nov 08, 2023

BUY
$434.7 - $599.3 $81,288 - $112,069
187 Added 8.09%
2,498 $1.34 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $19,290 - $25,793
55 Added 2.44%
2,311 $1.08 Million
Q1 2023

May 11, 2023

BUY
$310.63 - $364.82 $7,765 - $9,120
25 Added 1.12%
2,256 $774,000
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $8,681 - $10,116
-27 Reduced 1.2%
2,231 $816,000
Q3 2022

Nov 09, 2022

SELL
$296.48 - $337.87 $592 - $675
-2 Reduced 0.09%
2,258 $730,000
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $35,119 - $41,236
-126 Reduced 5.28%
2,260 $733,000
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $29,336 - $36,457
125 Added 5.53%
2,386 $683,000
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $1,124 - $1,395
-5 Reduced 0.22%
2,261 $625,000
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $142,045 - $174,807
641 Added 39.45%
2,266 $524,000
Q2 2021

Jul 30, 2021

BUY
$180.55 - $233.54 $180 - $233
1 Added 0.06%
1,625 $373,000
Q1 2021

May 10, 2021

SELL
$164.32 - $212.72 $49,296 - $63,816
-300 Reduced 15.59%
1,624 $303,000
Q4 2020

Feb 09, 2021

SELL
$130.46 - $172.63 $28,701 - $37,978
-220 Reduced 10.26%
1,924 $325,000
Q3 2020

Nov 10, 2020

BUY
$146.22 - $169.13 $21,055 - $24,354
144 Added 7.2%
2,144 $317,000
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $5,456 - $6,567
-40 Reduced 1.96%
2,000 $328,000
Q1 2020

May 14, 2020

BUY
$119.05 - $147.35 $11,905 - $14,735
100 Added 5.15%
2,040 $283,000
Q4 2019

Feb 03, 2020

BUY
$106.92 - $132.43 $207,424 - $256,914
1,940 New
1,940 $255,000
Q2 2019

Aug 09, 2019

SELL
$110.79 - $129.32 $173,718 - $202,773
-1,568 Closed
0 $0
Q1 2019

May 13, 2019

SELL
$111.31 - $131.02 $110,753 - $130,364
-995 Reduced 38.82%
1,568 $203,000
Q4 2018

Feb 11, 2019

BUY
$105.9 - $118.64 $2,965 - $3,321
28 Added 1.1%
2,563 $297,000
Q3 2018

Nov 14, 2018

SELL
$85.86 - $107.31 $48,596 - $60,737
-566 Reduced 18.25%
2,535 $272,000
Q2 2018

Aug 13, 2018

SELL
$75.7 - $86.88 $17,032 - $19,548
-225 Reduced 6.76%
3,101 $265,000
Q1 2018

May 15, 2018

SELL
$74.21 - $87.6 $46,084 - $54,399
-621 Reduced 15.73%
3,326 $257,000
Q4 2017

Feb 14, 2018

BUY
$81.94 - $87.89 $323,417 - $346,901
3,947
3,947 $333,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $749B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fort Point Capital Partners LLC Portfolio

Follow Fort Point Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Point Capital Partners LLC with notifications on news.